Extended-release lipid-foam encapsulated epidural morphine: Clinical efficacy and safety precautions

Rob Hutchison, PharmD

doi:10.5055/jom.2005.0018

Authors

Rob Hutchison, PharmD

DOI:

https://doi.org/10.5055/jom.2005.0018

Keywords:

-

Abstract

-

Author Biography

Rob Hutchison, PharmD

clinical pharmacy specialist in pain management at Presbyterian Hospital of Dallas and assistant professor at Texas Tech University Health Sciences Center School of Pharmacy, in Dallas, Texas. Contact author: robhutchison@texashealth.org.

References

DepoDur (morphine sulfate extended-release liposome injection) package insert. Endo Pharmaceuticals, Inc. May 2004.

Carvalho B, Riley E, Cohen S, et al.: Single-dose, sustainedrelease epidural morphine in the management of postoperative pain after elective cesarean delivery: Results of a multicenter randomized study. Anesth Analg. 2005; 100: 1150-1158.

Gambling D, Hughes T, Martin G: A comparison of DepoDur(r), a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery. Anesth Analg. 2005; 100: 1065-1074.

Cada D, Levien T, Baker D: Morphine sulfate extended-release liposomal injection. Hospital Pharmacy. 2004; 39(9): 871-879.

Institute for Safe Medicine Practices Newsletter. July 1, 2004.

Institute for Safe Medicine Practices Medication Safety Alert. 10(3); February 10, 2005.